AtriCure Inc. (ATRC)
NASDAQ: ATRC
· Real-Time Price · USD
29.27
-0.64 (-2.14%)
At close: May 01, 2025, 3:59 PM
29.29
0.05%
After-hours: May 01, 2025, 04:42 PM EDT
-2.14% (1D)
| Bid | 27.2 |
| Market Cap | 1.45B |
| Revenue (ttm) | 480.08M |
| Net Income (ttm) | -38.18M |
| EPS (ttm) | -0.81 |
| PE Ratio (ttm) | -36.14 |
| Forward PE | -71.5 |
| Analyst | Buy |
| Ask | 31.13 |
| Volume | 1,165,666 |
| Avg. Volume (20D) | 604,516 |
| Open | 29.92 |
| Previous Close | 29.91 |
| Day's Range | 28.32 - 29.78 |
| 52-Week Range | 18.94 - 43.11 |
| Beta | 1.65 |
About ATRC
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform tem...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Aug 5, 2005
Employees 1,300
Stock Exchange NASDAQ
Ticker Symbol ATRC
Website https://www.atricure.com
Analyst Forecast
According to 10 analyst ratings, the average rating for ATRC stock is "Buy." The 12-month stock price forecast is $51, which is an increase of 74.21% from the latest price.
Stock ForecastsEarnings Surprise
AtriCure has released their quartely earnings
on Apr 29, 2025:
2 days ago
-13.68%
AtriCure shares are trading lower after the compan...
Unlock content with
Pro Subscription
1 month ago
-7.39%
Atricutre shares are trading lower after Canaccord Genuity cut its price target on the stock from $66 to $52.
